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INTRODUCTION: Patient is a 73 year old female with past
medical history of colon cancer status post colectomy/
ileostomy with ileal conduit on chronic total parenteral
nutrition (TPN) who presented to the hospital for fatigue
and hypotension. She reported that the night prior, she had
an 8 hour lapse in her memory and a sensation of dyspnea.
In the ED, she was hypotensive and hypoxic. CTA of the
chest was notable for a small and nonocclusive right lower
lobe embolism, massive right heart strain with RV/LV 1.5
as well as innumerable bilateral centrilobular micronodules.
The above findings were not present on a scan done one
month prior and neither was the echocardiograph finding
of sudden onset pulmonary hypertension with RVSP 55.
In the setting of central venous access used for TPN and
no signs of infection, consideration was given to crystalline
induced microemboli. A bronchoscopy was performed which
showed polarizable material with occlusive granulomatous
inflammation along the vessel walls and confirmed the
diagnosis of excipient lung disease.
DESCRIPTION: Excipient lung disease is classically
associated with IV injection of crushed oral tablets such as
narcotics and stimulants. Excipients such as microcrystalline
cellulose and talc consist of inert filler materials which aid in
the binding of the active particles of the medications. When
these agents are deposited in the pulmonary vasculature,
there is an angiogranulomatous reaction resulting in
micronodules and microemboli which can potentiate cor
pulmonale and sudden cardiac arrest.
DISCUSSION: Excipient lung is a rare and often missed
diagnosis. When the disease process is considered, it is
typically attributed to injection of illicit drugs or controlled
substances, yet this case illustrates the importance of
recognizing TPN as a potential cause. Although most
formulations of TPN have microcrystalline cellulose which
do not cause any adverse reactions, this patient’s infusion
resulted in acute pulmonary hypertension, cor pulmonale and
diffuse occlusive pulmonary granulomatous micronodules.
This etiology is crucial to keep in the differential because
although uncommon, it can cause pulmonary fibrosis and
pulmonary hypertension which can result in poor functional
status, decreased lung compliance, heart failure and possible
cardiac arrest.
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INTRODUCTION: AS is an autoimmune condition,
characterized by antibodies directed against an aminoacyl
transfer RNA synthetase. AS has a highly heterogenous
disease pattern due to different organ involvement. The initial
clinical presentation can be variable. We present an atypical
case of AS with ARDS.
DESCRIPTION: A 72-year-old female, retired teacher,
with no significant past medical history presented to the
emergency department with complaints of progressively
worsening shortness of breath for 3 to 4 weeks, associated
with fever, nausea, vomiting, and diarrhea. Otherwise review of
symptoms was negative. Patient was hypotensive, tachycardic
and hypoxic requiring hi-flow nasal canula (FiO2 90%). A
chest CT was negative for thromboembolic disease but did
show bilateral patchy ground glass opacities with traction
bronchiectasis and confluent consolidation in both upper
lobes. Patient was admitted to the medical intensive care unit
and initiated on antibiotics, but her hypoxemia progressively
worsened requiring mechanical ventilation for ARDS. She
required multiple proning sessions. Her bronchoscopy
with bronchoalveolar lavage was negative for infectious
etiology including COVID test. Given her persistent hypoxia,
patient was started on methylprednisolone due to concerns
for interstitial lung disease (ILD). Patient’s oxygenation
significantly improved, and she was extubated 10 days later.
Further investigations revealed positive anti-PL-7 directed
against threonyl t-RNA synthetase. Case was discussed in the
ILD multidisciplinary conference with pulmonary and thoracic
surgery. In the light of her ongoing oxygen requirements,
there was high suspicion of rapidly progressive form of antisynthetase syndrome. Therefore, she was started on 60 mg
prednisone, tacrolimus, and cyclophosphamide. Patient was
discharged to a skilled-nursing facility.
DISCUSSION: AS can be a challenging diagnosis,
especially in patients without any muscular or rheumatological
symptoms that present with ARDS. It is critical to have a
broad differential for patients with non-resolving ARDS. ILD
as the initial presentation of AS is a major cause of mortality.
Currently there is limited evidence-based recommendations
to guide therapy. Additional randomized clinical trials would
be needed to support guidelines directing the management of
AS ILD flare.
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